C.T. Fitzpatrick’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-889,275
Closed -$41.1M 62
2016
Q2
$41.1M Sell
889,275
-1,730,653
-66% -$69.7M 0.4% 41
2016
Q1
$100M Sell
2,619,928
-893,553
-25% -$29.6M 0.9% 27
2015
Q4
$133M Buy
3,513,481
+719,525
+26% +$26.5M 1.24% 25
2015
Q3
$115M Sell
2,793,956
-71,671
-3% -$3.08M 1.12% 25
2015
Q2
$135M Buy
2,865,627
+494,561
+21% +$26.8M 1.28% 26
2015
Q1
$143M Sell
2,371,066
-2,248,909
-49% -$114M 1.42% 27
2014
Q4
$202M Buy
4,619,975
+1,310,252
+40% +$57.9M 2.29% 18
2014
Q3
$162M Buy
3,309,723
+2,164,187
+189% +$115M 2.3% 19
2014
Q2
$84.7M Buy
1,145,536
+422,728
+58% +$33.3M 1.25% 32
2014
Q1
$59.9M Buy
+722,808
New +$63.5M 1.06% 31

Other funds holding NUS

C.T. Fitzpatrick's NUS Position: Q3 2016 in Review

C.T. Fitzpatrick sold out of Nu Skin (NUS) in Q3 2016, closing a stake of 889,275 shares — an estimated $41.1M sold.

C.T. Fitzpatrick first reported a position in NUS in Q1 2014 and held it in 10 quarters. The position peaked at $202M in Q4 2014. 240 funds tracked by Wall St. Rank hold NUS as of Q3 2016.

  • C.T. Fitzpatrick reported no remaining Nu Skin position as of Q3 2016 after selling out during the quarter.
  • C.T. Fitzpatrick sold 889,275 Nu Skin shares in Q3 2016, an estimated $41.1M.
  • C.T. Fitzpatrick first reported a position in Nu Skin in Q1 2014 and held it in 10 quarters.
  • C.T. Fitzpatrick's Nu Skin position peaked at $202M in Q4 2014.
  • 240 funds tracked by Wall St. Rank held Nu Skin as of Q3 2016.

Based on Vulcan Value Partners's 13F filing for Q3 2016, filed 14 Nov 2016.